Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 95

1.

The brave new world of antiplatelet therapy: seeking clarity in a world of increasing choice and complexity.

Price MJ.

Rev Cardiovasc Med. 2011;12 Suppl 1:S1-3. No abstract available.

PMID:
22080982
2.

Editorial: Paving the way for improved antiplatelet therapy.

Grove EL.

Curr Pharm Des. 2012;18(33):5195-6. No abstract available.

PMID:
22724421
3.

Antiplatelet medications: old and emerging therapies.

Stone WM, Naidu SG, Chapital A, Money SR.

Ann Vasc Surg. 2010 Jan;24(1):140-8. doi: 10.1016/j.avsg.2009.03.008. Epub 2009 Jul 19. Review.

PMID:
19619976
4.

Antiplatelet drug response variability and the role of platelet function testing: a practical guide for interventional cardiologists.

Angiolillo DJ, Suryadevara S, Capranzano P, Zenni MZ, Guzman LA, Bass TA.

Catheter Cardiovasc Interv. 2009 Jan 1;73(1):1-14. doi: 10.1002/ccd.21782. Review.

PMID:
19089929
5.

Antithrombotic therapy in peripheral artery disease--antiplatelet therapy, anticoagulants, both or none.

Tangelder MJ, van Hattum ES.

Thromb Haemost. 2010 Aug;104(2):196-9. doi: 10.1160/TH10-02-0104. Epub 2010 May 27. No abstract available.

PMID:
20508897
6.

Antiplatelet therapy in percutaneous coronary intervention: a critical review of the 2007 AHA/ACC/SCAI guidelines and beyond.

Cohen M.

Catheter Cardiovasc Interv. 2009 Oct 1;74(4):579-97. doi: 10.1002/ccd.22021. Review.

PMID:
19472347
7.

Antiplatelet agents in acute coronary syndromes.

Sakhuja R, Yeh RW, Bhatt DL.

Curr Probl Cardiol. 2010 Mar;35(3):123-70. doi: 10.1016/j.cpcardiol.2009.11.002. Review.

PMID:
20152547
8.

Aspirin and Plavix: what every clinical nurse specialist should know now.

O'Malley P.

Clin Nurse Spec. 2007 Jan-Feb;21(1):13-5. Review. No abstract available.

PMID:
17213734
9.

Improving outcomes with antiplatelet therapies in percutaneous coronary intervention and stenting.

Hobson A, Curzen N.

Thromb Haemost. 2009 Jan;101(1):23-30. No abstract available.

PMID:
19132185
10.

Antiplatelet drugs: which targets for which treatments?

Gachet C.

J Thromb Haemost. 2015 Jun;13 Suppl 1:S313-22. doi: 10.1111/jth.12947. Review.

11.

Discordance between physicians' estimation of patient cardiovascular risk and use of evidence-based medical therapy.

Tsang JL, Mendelsohn A, Tan MK, Hackam DG, Leiter LA, Fitchett D, Lin PJ, Grima E, Langer A, Goodman SG; Vascular Protection Registry and Guidelines Oriented Approach to Lipid Lowering Registry Investigators.

Am J Cardiol. 2008 Nov 1;102(9):1142-5. doi: 10.1016/j.amjcard.2008.06.037. Epub 2008 Aug 15.

PMID:
18940280
12.

Antiplatelet agents: current drugs and future trends.

Messmore HL Jr, Jeske WP, Wehrmacher W, Coyne E, Mobarhan S, Cho L, Leya FS, Moran JF.

Hematol Oncol Clin North Am. 2005 Feb;19(1):87-117, vi. Review.

PMID:
15639110
13.

Dual antiplatelet therapy and antithrombotic treatment: Recommendations and controversies.

Bryniarski L, Pelc-Nowicka A, Zabojszcz M, Mirek-Bryniarska E.

Cardiol J. 2009;16(2):179-89. Review.

14.

Optimizing antiplatelet therapy following percutaneous coronary intervention: clinical pathways for platelet function testing.

Lassar TA, Simon DI, Croce K.

Rev Cardiovasc Med. 2011;12 Suppl 1:S23-33. Review.

PMID:
22080984
15.

New anti-coagulant therapies set to revitalise clinical haemotology practice.

Aalbers J, Wagenaar P, Klug E.

Cardiovasc J Afr. 2010 Nov-Dec;21(6):323-6, 337. No abstract available. Erratum in: Cardiovasc J Afr.2011 May-Jun;22(3):168.

16.

Investigating the mechanisms of hyporesponse to antiplatelet approaches.

Braunwald E, Angiolillo D, Bates E, Berger PB, Bhatt D, Cannon CP, Furman MI, Gurbel P, Michelson AD, Peterson E, Wiviott S.

Clin Cardiol. 2008 Mar;31(3 Suppl 1):I21-7. doi: 10.1002/clc.20360. Review. Erratum in: Clin Cardiol. 2009 Feb;32(2):111.

17.

Should we monitor platelet function during antiplatelet therapy?

Hjemdahl P.

Heart. 2008 Jun;94(6):685-7. doi: 10.1136/hrt.2007.135194. No abstract available.

PMID:
18480343
18.

Combined warfarin-aspirin therapy: what is the evidence for benefit and harm and which patients should (and should not) receive it?

Donadini MP, Douketis JD.

J Thromb Thrombolysis. 2010 Feb;29(2):208-13. doi: 10.1007/s11239-009-0413-4. Review.

PMID:
19915994
19.
20.

Dual antiplatelet therapy in the secondary prevention of atherothrombosis: need for new therapeutic approaches.

Sabatier B, Trinquart L, Emmerich J.

Arch Cardiovasc Dis. 2010 Oct;103(10):497-501. doi: 10.1016/j.acvd.2010.06.007. Epub 2010 Nov 3. Review. No abstract available.

Supplemental Content

Support Center